{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:37:03Z","timestamp":1783453023513,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejphar.2026.178735","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:13:16Z","timestamp":1772784796000},"page":"178735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Functional selectivity of cannabinoids at CB1 receptors: Comprehensive analysis of G proteins, \u03b2-arrestin and cAMP signalling dynamics in HEK293T cells"],"prefix":"10.1016","volume":"1019","author":[{"given":"Noor","family":"AlAli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-4777","authenticated-orcid":false,"given":"Benjamin J.","family":"Wheaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-8499","authenticated-orcid":false,"given":"Stig O.P.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178735_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/jm00038a020","article-title":"(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability","volume":"37","author":"Abadji","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib2","doi-asserted-by":"crossref","first-page":"12070","DOI":"10.1074\/jbc.M111.316463","article-title":"Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1\/2 kinase activation","volume":"287","author":"Ahn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib3","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M112.438804","article-title":"Distinct roles of \u03b2-arrestin 1 and \u03b2-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1)","volume":"288","author":"Ahn","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib4","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","volume":"13","author":"Anand","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2026.178735_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ijo.2010.21","article-title":"A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study","volume":"34","author":"Aronne","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ejphar.2026.178735_bib6","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1074\/jbc.272.35.22330","article-title":"A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor\/ligand interactions","volume":"272","author":"Bouaboula","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FBP.0b013e328308f1e6","article-title":"Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -\/- mice","volume":"19","author":"Breivogel","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2011.01425.x","article-title":"Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium","volume":"164","author":"Brighton","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib9","doi-asserted-by":"crossref","first-page":"R2185","DOI":"10.1152\/ajpregu.00663.2007","article-title":"A neutral CB1 receptor antagonist reduces weight gain in rat","volume":"293","author":"Chambers","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2026.178735_bib10","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1476-5381.2010.01006.x","article-title":"Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to Gs and Gi","volume":"161","author":"Chen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178735_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fpsyt.2019.00063","article-title":"The endocannabinoid system and Cannabidiol's promise for the treatment of substance use disorder","volume":"10","author":"Chye","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.178735_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejphar.2026.178735_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of biased \u03b2-Arrestin-Mediated signaling downstream from the cannabinoid 1 receptor","volume":"89","author":"Delgado-Peraza","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.69","article-title":"Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats","volume":"2","author":"Ding","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejphar.2026.178735_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/jbcpp-2015-0096","article-title":"CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi\/o function","volume":"27","author":"Eldeeb","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178735_bib18","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/bph.13866","article-title":"G\u03b1s signalling of the CB1 receptor and the influence of receptor number","volume":"174","author":"Finlay","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pbb.2005.01.023","article-title":"The endocannabinoid signaling system: pharmacological and therapeutic aspects","volume":"81","author":"Fowler","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178735_bib20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4155\/fmc-2019-0005","article-title":"Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery","volume":"11","author":"Gado","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib21","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178735_bib22","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1111\/bph.16433","article-title":"Positive allosteric modulation of the cannabinoid CB1 receptor potentiates endocannabinoid signalling and changes ERK1\/2 phosphorylation kinetics","volume":"181","author":"Green","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib23","doi-asserted-by":"crossref","first-page":"21995","DOI":"10.1016\/S0021-9258(18)41623-7","article-title":"Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide","volume":"267","author":"Guan","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib24","doi-asserted-by":"crossref","first-page":"pyw068","DOI":"10.1093\/ijnp\/pyw068","article-title":"The CB1 neutral antagonist AM4113 retains the therapeutic efficacy of the inverse agonist rimonabant for nicotine dependence and weight loss with better psychiatric tolerability","volume":"19","author":"Gueye","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41591-023-02381-w","article-title":"Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials","volume":"29","author":"Haney","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178735_bib26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178735_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","article-title":"PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats","volume":"152","author":"Horswill","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB(1) cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"Hsieh","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178735_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 receptor-mediated arrestin translocation: species, subtype, and agonist-dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib31","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178735_bib32","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178735_bib33","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-023-37864-4","article-title":"Structural basis for activation of CB1 by an endocannabinoid analog","volume":"14","author":"Krishna Kumar","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178735_bib34","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178735_bib36","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178735_bib37","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178735_bib38","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1016\/j.cell.2023.11.017","article-title":"Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism","volume":"186","author":"Liao","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.178735_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41401-018-0164-x","article-title":"Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor","volume":"40","author":"Lu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.178735_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"LuThomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bph.15973","article-title":"Cannabinoid 1 (CB1) receptor arrestin subtype-selectivity and phosphorylation dependence","volume":"180","author":"Manning","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175642","article-title":"Mini-G proteins: novel tools for studying GPCRs in their active conformation","volume":"12","author":"Nehm\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178735_bib43","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1523\/JNEUROSCI.22-10-03864.2002","article-title":"Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses","volume":"22","author":"Ohno-Shosaku","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178735_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/mol.54.6.1064","article-title":"SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity","volume":"54","author":"Pan","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib45","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178735_bib46","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor","volume":"68","author":"Price","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2026.178735_bib48","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1074\/jbc.M113.478495","article-title":"Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling","volume":"289","author":"Shore","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178735_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(01)00784-1","article-title":"Inhibitory effects of SR141716A on G-protein activation in rat brain","volume":"414","author":"Sim-Selley","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178735_bib50","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/jcm14082851","article-title":"The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review","volume":"14","author":"Simankowicz","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2026.178735_bib51","doi-asserted-by":"crossref","first-page":"14990","DOI":"10.1074\/jbc.M109.099689","article-title":"Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form","volume":"285","author":"Tubio","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:43:01Z","timestamp":1779424981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0014299926002177"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178735","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional selectivity of cannabinoids at CB1 receptors: Comprehensive analysis of G proteins, \u03b2-arrestin and cAMP signalling dynamics in HEK293T cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178735"}}